techgroup header image oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells

therapoid
  • New development of oHSV for cancer treatment
    Sponsored by Open Therapeutics™ on 2022-02-22 09:15 UTC
    Open for proposal submissions from 2022-12-31 16:24 UTC and voting against this grant starts from 2023-04-01 00:00 UTC